← All Sponsors
SPONSOR

H. Lundbeck A/S

Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: Chronic Migraine in ChildrenEpisodic MigraineMigraineCongenital Adrenal Hyperplasia
NCT04965675 Phase 3
Recruiting

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

Chronic Migraine in Children
United States, Argentina, Canada View Trial →
NCT05897320 Phase 3
Recruiting

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Episodic Migraine
United States, Argentina, Canada View Trial →
NCT05164172 Phase 3
Recruiting

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

Migraine
United States, Argentina, Canada View Trial →
NCT05669950 Phase 1, Phase 2
Recruiting

A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia
United States, Denmark, France View Trial →